Fig. 10 | Scientific Reports

Fig. 10

From: Super-enhancer-driven SLCO4A1-AS1 is a new biomarker and a promising therapeutic target in glioblastoma

Fig. 10

Overexpression of SLCO4A1-AS1 could rescue the inhibitory effect of VX-11e on GSC stemness. (A, B) qRT-PCR was performed to examine the expression of stemness markers after treatment under the conditions indicated in GBM#P3 (A) and GBM#BG5 (B) (n = 3). (C, D) Sphere forming ability (C) and tumor sphere expansion capacity (D) were examined after treatment with the indicated conditions in GBM#P3 and GBM#BG5 (n = 3). Scale bar = 50 μm. Data are presented as the mean ± SD. NS, not statistically significant; * P < 0.05; ** P < 0.01; *** P < 0.001. 1-way ANOVA was used for data analysis.

Back to article page